SoCal Centers of Excellence

Robotic prostatectomy: High volume with outstanding functional outcomes.

Brachytherapy and IMRT: Strong radiation team with expertise in combined modality treatment.

Complex case management: Especially for high-risk or locally advanced cancers.

Clinical trials: Focused on imaging, hormone blockade intensification, and genetic markers.

High-volume robotic prostatectomy: USC urologists are leaders in minimally invasive surgical techniques, including nerve-sparing approaches.

Expert management of advanced and high-risk disease: Multimodal strategies combining surgery, radiation, and systemic therapies.

National reputation: Known for excellence in academic medicine and cancer research.

Advanced radiation therapy: Offers SBRT, IMRT, and brachytherapy.

Robust clinical trial portfolio: Access to trials in hormone therapy intensification, imaging agents, and molecular stratification.

Robotic and open radical prostatectomy: World-class surgical team with focus on preserving function.

Advanced radiation therapy: Pioneers in SBRT (e.g., 5-fraction regimens) and image-guided IMRT.

Focal therapy: Offers HIFU, cryotherapy, and partial gland ablation in selected patients.

Multidisciplinary care: Urology, oncology, radiology, and pathology integrated.

Extensive clinical trials: Access to novel hormone agents, targeted therapies, and immunotherapies.

Molecular diagnostics and active surveillance leadership.

Academic research and trials: Wide access to novel hormonal agents and precision therapies.

High-quality IMRT/SBRT delivery: Advanced image-guided radiation oncology.

Prostate-focused medical oncology: Strength in treating metastatic and castration-resistant disease.

Integrated care with access to specialists in molecular profiling and immunotherapy.

Robotic surgery excellence: Strong focus on preserving urinary and sexual function, with experienced surgical teams.

MRI fusion biopsy: Allows precise diagnosis and aids in focal therapy or active surveillance decisions.

Radiation oncology program: Offers full range of external beam treatments, including IMRT and SBRT.

Academic center: Patients receive evidence-based care with access to clinical trials and emerging technologies.

Personalized treatment planning: Tailored care for localized, high-risk, and metastatic prostate cancer.

SBRT and IMRT: Precision radiation options, with access to MD Anderson protocols.

Systemic therapy and immunotherapy: Access to advanced agents through MD Anderson affiliation.

Multidisciplinary team-based care: Emphasis on collaborative treatment planning.

Robotic/laparoscopic prostatectomy: Focus on minimally invasive, nerve-sparing techniques.

Advanced radiation options: SBRT and IMRT with a focus on functional outcomes.

Precision medicine focus: Genomic testing to personalize treatment.

Small, high-touch environment: Combines academic-level care with a boutique setting.

Proton beam therapy: World pioneer in hospital-based proton therapy; ideal for patients wanting highly targeted radiation.

Experience with combination therapy: Proton + hormonal therapy in intermediate- and high-risk disease.

Holistic approach: Offers spiritual and psychological support as part of cancer care.

High-volume robotic prostatectomy: Standardized techniques across their system.

Integrated care model: Seamless access to urology, radiation, and oncology within one system.

Strong active surveillance program: Data-driven decision-making, avoids overtreatment.

Patient education and navigation: Emphasis on informed consent and continuity.

Focal cryotherapy: Among the earliest adopters and leaders in focal therapy.

MRI fusion biopsy: Precision diagnosis for targeted treatment.

Personalized care: Emphasis on quality of life and functional preservation.

Multidisciplinary team: Includes urologists, radiation oncologists, and nurse navigators.

Extension of City of Hope expertise: Offers the same high standard of care as the Duarte campus, with access to surgical, radiation, and systemic therapies.

Robotic prostate surgery: Performed by expert urologic surgeons with access to specialized imaging and minimally invasive techniques.

Advanced radiation therapy: Includes IMRT and image-guided techniques for precise delivery.

Integrated care: Patients benefit from a multidisciplinary clinic where urologists, oncologists, radiation specialists, and support staff collaborate.

Access to Duarte-based clinical trials: Genomic profiling, immunotherapy, and novel agents are available through seamless referral.

Comprehensive prostate cancer program: Integrates surgery, radiation, systemic therapy, and research.

Robotic radical prostatectomy: High surgical volume and nerve-sparing techniques.

Brachytherapy and IMRT/VMAT: Extensive experience with both high- and low-dose brachytherapy and advanced radiation delivery.

Proton therapy: Now available through partnerships.

Focal therapies under investigation: Cryotherapy and laser ablation explored via clinical trials.

Hormone, chemotherapy, and immunotherapy: Full medical oncology services, including sipuleucel-T (Provenge).

Leading-edge research: NCI-designated center with active clinical trials and molecular profiling.

Robotic-assisted radical prostatectomy: Performed by surgeons with extensive experience and a focus on outcomes.

National leadership: Cedars-Sinai is consistently ranked among the top urology and cancer programs.

Personalized molecular testing: Incorporates genetic and genomic data to guide treatment decisions.

Comprehensive options: Radiation, surgery, hormone therapy, and chemotherapy available in one center.

Survivorship and support services: Integrates physical therapy, psycho-oncology, and long-term side-effect management.

Exclusive focus on proton therapy: One of the few centers in California specializing in proton beam treatment.

Pencil beam scanning: Highly precise form of proton therapy that spares healthy tissue better than traditional radiation.

Minimal side effects: Particularly beneficial for preserving bladder, bowel, and sexual function.

Ideal for early and intermediate-risk prostate cancer: Proton therapy is frequently used as a standalone treatment in these cases.

Collaborative care model: Works with outside urologists and oncologists to offer proton therapy as part of coordinated treatment.